BMY – Bristol-Myers Squibb Co

Bristol-Myers Squibb Company is a biopharmaceutical company, which is engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for a range of therapeutic classes, which include oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically-synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, Breyanzi, Camzyos, Sotyktu, Onureg, Inrebic, Augtyro, and others. It also provides radiopharmaceutical therapeutics.